SCHEMBL22453809

SCHEMBL22453809

Cc1ncc(N=O)cc1B1OC(C)(C)C(C)(C)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14800589 0.80 CCR1 (0.32) —
SCHEMBL30236983 0.76 PDGFRB (0.31) —
SCHEMBL22657170 0.76 FFAR1 (0.32) —
SCHEMBL31378591 0.76 LPL (0.39) —
SCHEMBL17752336 0.76 LPL (0.39) —
SCHEMBL16094541 0.76 PDGFRB (0.31) —
SCHEMBL15923768 0.76 EGFR (0.33) —
SCHEMBL30078243 0.74 ALDH1A1 (0.36) —
SCHEMBL4729108 0.74 ALDH1A1 (0.36) —
SCHEMBL27050551 0.73 KDM4E (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020190754-A1 MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS Fulcrum Therapeutics, Inc. (US) 2020-09-24 — — WO disclosed
Send feedback